Pediatrics

FDA OK's Diabetic Neuropathy Capsaicin Patch; EDCs Still a Threat





(MedPage Today) -- The FDA approved an 8% capsaicin patch (Qutenza) for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults, Grünenthal and Averitas Pharma announced.
During the pandemic...

Source link








Related posts

As Schools Reopen, Many Students, Staff Live With High-Risk Family Member

Newsemia

ASH: Research revises classification of acute myeloid leukemia and myelodysplastic syndrome

Newsemia

Early Talk, Interaction Predicts School-Age Language Outcomes

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy